Aquaporin-4 plays an integral role in brain inflammation New research in the FASEB Journal suggests that aquaporin-4, a water transporting protein, plays a role in brain inflammation via a mechanism involving astrocyte swelling and cytokine to push out a new protein, called aquaporin-4, is certainly making waves and found to play an integral function in brain inflammation, or encephalitis eriacta 100 reviews . This discovery is definitely important as the first ever to identify a function because of this protein in inflammation, opening doors for the development of new drugs that treat brain irritation and other conditions at the cellular level rather than just dealing with the symptoms. This discovery was released in the May 2011 problem of The FASEB Journal ( Our research establishes a novel function for a water channel, aquaporin-4, in neuroinflammation, as well as a cell-level mechanism, stated Alan S.
Sunday, June 1, 2014, 8:00 AM to 11:45 AM S Hall A2, Poster Table #90 James I. Geller, MD.. ArQule to present tivantinib clinical trial data in ASCO 2014 ArQule, Inc. today announced that tivantinib will end up being contained in seven presentations through the 2014 Annual Achieving of the American Society of Clinical Oncology to be kept from May 30, 2014 to June 3, 2014 in Chicago, Illinois. The presentations shall feature tivantinib in medical trials across multiple diseases and therapeutic combinations. Data will relate to the basic safety and combinability of tivantinib with approved anti-cancer agents, supporting the ongoing advancement of this compound. The most advanced ongoing medical trial with tivantinib is normally a pivotal Stage 3 randomized, double-blind controlled study of the substance as one agent therapy in previously treated sufferers with MET-diagnostic-high, inoperable hepatocellular carcinoma .